InvestorsHub Logo
Followers 8
Posts 1858
Boards Moderated 0
Alias Born 07/31/2021

Re: Karlchen post# 231568

Monday, 04/01/2024 1:03:37 PM

Monday, April 01, 2024 1:03:37 PM

Post# of 233055
Yes they can start then, but to say that CYDY would be years ahead of them would be false. For example, if they decided to start pursuing the indication for inflammation they would have the resources to get ahead of cash poor CYDY who doesn't have the money to run clinical trials or even hire a CRO. Also, this is assuming any new entrant would not have experience with CCR5 inhibitors when generic Maraviroc has been available for a while now and they could have been using that for any existing research.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News